Monday June 22, 0800-1030
Leonard Jeffrey Medeirios, The University of Texas MD Anderson Cancer Center
Diffuse Large B-cell Lymphoma
At the end of this session, participants will be able to:
Diagnose morphologic variants and subtypes of diffuse large B-cell lymphoma recognized in the World Health Organization classification.
Recognize clinicopathologic and immunophenotypic findings that have prognostic value in patients with diffuse large B-cell lymphoma.
Apply results of conventional cytogenetic analysis and fluorescence in situ hybridization to enhance diagnosis of diffuse large B-cell lymphoma.